58. Cramer D, Ward S, Geddes D. Assessment of oxygen
supplementation during air travel. Thorax 1996;51:202–3.
59. Agusti A, Hedner J, Marin JM, et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev
60. Kinsman RA, Yaroush RA, Fernandez E, et al. Symptoms
and experiences in chronic bronchitis and emphysema.
61. Flenley DC. Sleep in chronic obstructive lung disease. Clin
Chest Med 1985;6:651–61.
62. Sanders MH, Newman AB, Haggerty CL, et al. Sleep and
sleep-disordered breathing in adults with predominantly
mild obstructive airway disease. Am J Respir Crit Care
Med 2003;167: 7–14.
63. Bednarek M, Plywaczewski R, Jonczak L, Zielinski J.
There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a
population study. Respiration 2005;72:142–9.
64. Sharma B, Feinsilver S, Owens RL, et al. Obstructive airway disease and obstructive sleep apnea: effect of pulmonary function. Lung 2011;189:37–41.
65. Hawrylkiewicz I, Sliwinski P, Gorecka D, et al. Pulmonary
haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch Chest Dis 2004;61:148–52.
66. Mermigkis C, Kopanakis A, Foldvary-Schaefer N, et al.
Health-related quality of life in patients with obstructive
sleep apnoea and chronic obstructive pulmonary disease
(overlap syndrome). Int J Clin Pract 2007;61:207–11.
67. McNicholas WT. Chronic obstructive pulmonary disease
and obstructive sleep apnea: overlaps in pathophysiology,
systemic inflammation, and cardiovascular disease. Am J
Respir Crit Care Med 2009;180:692–700.
68. Marin JM, Soriano JB, Carrizo SJ, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir
Crit Care Med 2010;182:325–31.
69. Celli BR, MacNee W. Standards for the diagnosis and treat
ment of patients with COPD: a summary of the ATS/ERS
position paper. Eur Respir J 2004;23:932–46.
70. Machado MC, Vollmer WM, Togeiro SM, et al. CPAP
and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J
71. Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure
nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD):
a 24-month follow-up study. Sleep Breath 2010;14:115–23.
72. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl
J Med 2010;363:1128–38.
73. Plant PK, Owen JL, Elliott MW. Non-invasive ventilation
in acute exacerbations of chronic obstructive pulmonary
disease: long term survival and predictors of in-hospital
outcome. Thorax 2001;56:708–12.
74. Plant PK, Owen JL, Elliott MW. One year period prevalence
study of respiratory acidosis in acute exacerbations of
COPD: implications for the provision of non-invasive ventilation and oxygen administration. Thorax 2000;55:550– 4.
75. Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic
respiratory failure in patients with chronic obstructive lung
disease: risk factors and use of guidelines for management. Thorax 1992;47:34–40.
76. Garpestad E, Brennan J, Hill NS. Noninvasive ventilation
for critical care. Chest 2007;132:711–20.
77. Confalonieri M, Garuti G, Cattaruzza MS, et al. A chart
of failure risk for noninvasive ventilation in patients with
COPD exacerbation. Eur Respir J 2005;25:348–55.
78. Budweiser S, Jorres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis
79. Ferrer M, Valencia M, Nicolas JM, et al. Early noninvasive ventilation averts extubation failure in patients
at risk: a randomized trial. Am J Respir Crit Care Med
80. Chailleux E, Fauroux B, Binet F, et al. Predictors of survival in patients receiving domiciliary oxygen therapy or
mechanical ventilation. A 10-year analysis of ANTADIR
Observatory. Chest 1996;109:741–9.
81. Costello R, Deegan P, Fitzpatrick M, McNicholas WT.
Reversible hypercapnia in chronic obstructive pulmonary
disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997;102:239–44.
82. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung
disease, COPD, and nocturnal hypoventilation--a consensus conference report. Chest 1999;116:521–34.
83. Windisch W, Haenel M, Storre JH, Dreher M. High-inten-sity non-invasive positive pressure ventilation for stable
hypercapnic COPD. Int J Med Sci 2009;6:72–6.
84. Dreher M, Storre JH, Schmoor C, Windisch W. High-inten-sity versus low-intensity non-invasive ventilation in patients
with stable hypercapnic COPD: a randomised crossover
trial. Thorax 2010;65:303–8.
85. Duiverman ML, Wempe JB, Bladder G, et al. Nocturnal
non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax 2008;63:1052–7.
86. Corner E, Garrod R. Does the addition of non-invasive
ventilation during pulmonary rehabilitation in patients with
chronic obstructive pulmonary disease augment patient
outcome in exercise tolerance? A literature review. Physio-ther Res Int 2010;15: 5–15.
87. Criner GJ, Belt P, Sternberg AL, et al. Effects of lung volume